Logo for Amarin Corporation plc

Amarin Corporation Investor Relations Material

Latest events

Logo for Amarin Corporation plc

Q4 2023

Amarin Corporation
Logo for Amarin Corporation

Q4 2023

29 Feb, 2024
Logo for Amarin Corporation

Q3 2023

1 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Amarin Corporation plc

Access all reports
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. The company's lead drug is Vascepa (icosapent ethyl) capsules, which are used in the treatment of dyslipidemia; additionally, its product portfolio includes Vascepa combination studies with ezetimibe and with other lipid-modifying agents. The company also develops PEGylated lipase inhibitors for patients suffering from hypertriglyceridemia in worldwide markets.